Search results for "Coronavirus"
Latest COVID-19 research on VTE risk, treatment with metformin, ivermectin, fluvoxamine
Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.
https://immattersacp.org/weekly/archives/2022/08/23/4.htm
23 Aug 2022
IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir
The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital profits during the pandemic.
https://immattersacp.org/weekly/archives/2022/05/17/2.htm
17 May 2022
Oral medications for COVID-19 underused among socially vulnerable, CDC study finds
By late May, the rate of prescriptions for molnupiravir and nirmatrelvir/ritonavir was twice as high in the highest-income U.S. ZIP codes as in the lowest, research showed. A CDC webinar on June 28 will discuss efforts to equitably distribute these treatments.
https://immattersacp.org/weekly/archives/2022/06/28/2.htm
28 Jun 2022
Vote for your favorite entry
ACP Internist Weekly's cartoon caption contest continues. Readers can vote for their favorite caption to determine the winner.
https://immattersacp.org/weekly/archives/2022/01/18/7.htm
18 Jan 2022
And the winner is …
ACP Internist Weekly has tallied the voting from its latest cartoon contest, where readers are invited to match wits against their peers to provide the most original and amusing caption.
https://immattersacp.org/weekly/archives/2022/01/25/7.htm
25 Jan 2022
Fourth vaccine dose 62% effective against severe COVID-19 in month after receipt
Retrospective data from Israel showed that in people ages 60 years and older, an additional booster dose of the Pfizer-BioNTech COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization.
https://immattersacp.org/weekly/archives/2022/04/19/4.htm
19 Apr 2022
Studies examine persistent symptoms of COVID-19
A U.K. study found that COVID-19 vaccination after infection may help persistent symptoms, while a U.S. study found that the burden of such symptoms appears high.
https://immattersacp.org/weekly/archives/2022/05/24/5.htm
24 May 2022
Advice on monoclonal antibodies; new data on long-term COVID-19 symptoms, vaccine efficacy
The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
https://immattersacp.org/weekly/archives/2021/09/14/2.htm
14 Sep 2021
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VII: Challenging Clinical Questions
During the Dec. 8 virtual live event, a panel of experts will provide answers to common questions about COVID-19 that physicians face today.
https://immattersacp.org/weekly/archives/2021/11/23/2.htm
23 Nov 2021
Latest pandemic research looks at persistent symptoms of COVID-19, rise in alcohol deaths
More than half of patients with mild COVID-19 reported symptoms months later in one study, while another found psychiatric and neurologic consequences were similar in ICU survivors with and without COVID-19. Other research looked at the rise in alcohol-related deaths and the safety of vaccination during pregnancy.
https://immattersacp.org/weekly/archives/2022/03/29/4.htm
29 Mar 2022